Analyst Articles

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a... Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this... Read More